Kenneth D. Pearsen
Directeur Général chez Western New York Radiology Associates LLC
Profil
Kenneth D.
Pearsen is currently the Chief Executive Officer at Radiology Imaging Associates PC, Western New York Radiology Associates LLC, and Chief Radiology at Buffalo General Hospital.
He previously worked as a Director at HepaLife Technologies, Inc. in 2011 and as an Independent Director at Alliqua BioMedical, Inc. from 2011 to 2014.
Pearsen received his undergraduate degree from the University of Pennsylvania and his doctorate from Columbia University College of Physicians & Surgeons.
Postes actifs de Kenneth D. Pearsen
| Sociétés | Poste | Début |
|---|---|---|
| Western New York Radiology Associates LLC | Directeur Général | 11/01/2011 |
Radiology Imaging Associates PC
 Radiology Imaging Associates PC Medical/Nursing ServicesHealth Services Radiology Imaging Associates PC offers radiology services. Its services include genetic counseling, colonography screening, lung cancer screening and mammography screening. The company is headquartered in Englewood, CO. | Directeur Général | 11/01/2011 |
| Buffalo General Hospital | Corporate Officer/Principal | 01/04/2003 |
Anciens postes connus de Kenneth D. Pearsen
| Sociétés | Poste | Fin |
|---|---|---|
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Directeur/Membre du Conseil | 22/07/2014 |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Directeur/Membre du Conseil | 06/01/2011 |
Formation de Kenneth D. Pearsen
| University of Pennsylvania | Undergraduate Degree |
| Columbia University College of Physicians & Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Radiology Imaging Associates PC
Radiology Imaging Associates PC Medical/Nursing ServicesHealth Services Radiology Imaging Associates PC offers radiology services. Its services include genetic counseling, colonography screening, lung cancer screening and mammography screening. The company is headquartered in Englewood, CO. | Health Services |
| Buffalo General Hospital | |
| Western New York Radiology Associates LLC | |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
